What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Amplicor
96%DGNews: Amplicor HIV Monitor Test Recommended for Approval by FDA
96%DGNews: Amplicor HIV-1 Monitor(tm) Test First to Receive FDA Marketing Clearance
89%DGNews: ICAAC: Sustiva Combo May Provide Alternative Treatment For HIV/AIDS
88%DGNews: Amplicor CT/NG Test For Chlamydia And Gonorrhea Gives Same-Day Results
85%DGNews: ROI CONFERENCE: Triple Therapy With Ziagen Effective For Up To 48 Weeks
84%DGNews: FDA Approves Ziagen For Inclusion In AIDS/HIV Combination Drug Therapy
83%DGNews: EASL: Adefovir Dipivoxil Promising In Treatment Of Chronic Hepatitis B
83%DGNews: Sustiva Approved In U.S. As Part Of HIV Combination Therapy
83%DGNews: ICAAC: Previously-Treated Adults With HIV May Benefit From Combivir With Ziagen
82%DGNews: ROI CONFERENCE: Use Of Rescriptor With Indinavir At Lower Doses Decreases Viral Load
82%DGNews: Anti-HIV Combo Of Ziagen+Combivir Equivalent To Crixivan+Combivir At 24 Weeks
82%DGNews: AASLD: Pegasys Shows Efficacy In Chronic Hepatitis C Patients With Cirrhosis
82%DGNews: DDW: More Patients With Chronic Hepatitis C Respond To Pegasys Than Interferon
81%DGNews: FDA Advisory Committee Unanimously Recommends Approval of Pegasys (Peginterferon Alfa-2a) in Combination with Copegus (Ribavirin) for Hepatitis C
81%DGNews: Roche's Ribavirin Copegus Available In All EU Countries Within Months
81%DGNews: DDW: Pegasys and Ribavirin Effective at 24 weeks in Patients With Hepatitis C and Advanced Fibrosis/Cirrhosis
81%DGNews: HIV Treatment With Ziagen Plus Combivir Is Convenient And Effective
81%DGNews: Twice-Daily Viracept Demonstrates Anti-HIV Activity At 48 Weeks
81%DGNews: ICAAC: Results Show Agenerase Effective In AIDS Patients
81%DGNews: FDA Approves Agenerase For HIV Treatment
80%DGNews: DG DISPATCH - CROI: Once Daily Indinavir/Ritonavir Suppresses HIV, Increases CD4 Counts
79%DGNews: CSCI-RCPSC: Consensus Interferon Effective In Hepatitis C Non-Responders
79%DGNews: DDW: Pegasys (Pegylated IFN Alpha-2a) Shown Effective, Safe And Tolerable For Chronic Hepatitis C
79%DGNews: ROI CONFERENCE: Viracept Therapy Produces Anti-HIV Effects In Women At 12 Months
79%DGNews: Ziagen And Combivir Effective In HIV And Have Simple Dosing Schedules
79%DGNews: AIDS 2000: Viramune (Nevirapine)-Based Treatment Combo Comparable To Protease Inhibitor-Based Regimen In HIV Therapy
79%DGNews: Capravirine Demonstrates Anti-HIV Activity, Good Tolerability
79%DGNews: HIV Levels Undetectable In Patients Taking Sustiva
78%DGNews: Idenix Reports Preliminary 24-Week Phase IIa Clinical Trial Data for Valopicitabine (Nm283) in Combination With Pegylated Interferon for Treatment of Hepatitis C
78%DGNews: Pegasys (Peginterferon alfa-2a) More Tolerable Treatment for Hepatitis C Patients
78%DGNews: AIDS 2000: Viramune (Nevirapine) Combination Suppresses HIV In Advanced HIV/AIDS
77%DGNews: DT-HIV: Solo Trial Shows Promise GW433908 Plus Ritonavir Therapy Holds Promise in Treatment of HIV
77%DGNews: DG DISPATCH - CROI: Efavirenz Combination Keeps Viral Loads Undetectable For Two Years
77%DGNews: AIDS 2000: Triple Combination Therapies For HIV Compared
77%DGNews: ICDCD: Rescriptor May Result In Protease Inhibitor Dose Reduction, Simpler Dosing Schedule
76%DGNews: ROI CONFERENCE: New Test May Provide Earlier Detection Of HIV In Newborns
75%DGNews: DDW: Pegasys Dosing Comparable For Cirrhotic And Non-Cirrhotic Patients With Chronic Hep C
75%DGNews: ROI CONFERENCE: Sustiva Combination Can Suppress HIV To Undetectable Levels
74%DGNews: EASL: New Data Support Hepsera's Long-Term Efficacy Against Chronic Hepatitis B
74%DGNews: ICAAC: T-20 Containing Regimens Reduce HIV In Heavily Pre-Treated Patients
74%DGNews: FDA Grants Traditional Approval To Crixivan For HIV
70%DGNews: HIV/AIDS MEETING: Sustiva Effective, More Cost Effective Than Protease Inhibitor
69%DGNews: Pegasys Marketing Authorisation Granted By European Commission COPEGUS
66%DGNews: FDA Approves Pegasys (Peginterferon Alfa-2a) Combination With Copegus (Ribavirin) For Hepatitis C Treatment
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.